NASDAQ:URGN | Cash Flow Statement | UroGen Pharma Ltd.

Complete source-backed cash-flow history.

Available history
2015-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$14.35M$100,000.00
2026-03-31-$23.57M$75,000.00-$45.32M$54,000.00-$20.69M$65.2M
2025-12-31-$26.36M$75,000.00-$38.33M$17,000.00$27.72M$31.32M
2025-09-30-$33.35M$100,000.00
2025-06-30-$49.94M$100,000.00
2025-03-31-$43.84M$72,000.00-$42.02M$44,000.00-$25.96M$34,000.00
2024-12-31-$37.51M$68,000.00-$13.62M$115,000.00$60.62M$71,000.00
2024-09-30-$23.67M$100,000.00
2024-06-30-$33.4M$100,000.00
2024-03-31-$32.29M$123,000.00-$31.74M$0.00$13.52M$54.66M
2023-12-31-$26.02M$190,000.00-$13M$56,000.00-$11.34M$40,000.00
2023-09-30-$21.88M$200,000.00
2023-06-30-$24.14M$200,000.00
2023-03-31-$30.21M$217,000.00-$25.81M$23,000.00$6.27M$671,000.00
2022-12-31-$28.87M$236,000.00-$21.75M$13,000.00$23.11M$25.37M
2022-09-30-$25.83M$200,000.00
2022-06-30-$26.69M$200,000.00
2022-03-31-$28.39M$215,000.00-$24M$25,000.00$13.6M$70.74M
2021-12-31-$28.45M$213,000.00-$20.07M$202,000.00$9.13M-$32,000.00
2021-09-30-$30.21M$200,000.00
2021-06-30-$26.22M$200,000.00
2021-03-31-$25.94M$191,000.00-$27.4M$287,000.00$15.02M$4,000.00
2020-12-31-$30.53M$121,000.00-$21.24M$172,000.00$49.47M$78,000.00
2020-09-30-$28.82M$100,000.00
2020-06-30-$31.35M$100,000.00
2020-03-31-$37.79M$100,000.00-$35.64M$96,000.00$13.03M$90,000.00
2019-12-31-$38.97M$100,000.00-$26M$192,000.00$9.3M$245,000.00
2019-09-30-$22.25M$100,000.00
2019-06-30-$22.48M$100,000.00
2019-03-31-$21.44M$100,000.00-$17.93M$44,000.00-$44,000.00$163.51M
2018-12-31-$23.72M$200,000.00-$10.28M$24,000.00-$26,000.00$2.2M
2018-09-30-$20.53M$100,000.00
2018-06-30-$18.03M$47,539.00
2018-03-31-$13.38M$200,000.00-$9.62M$72,000.00$35.83M$64.26M
2017-12-31-$10.09M-$5.96M$153,000.00-$36.05M-$56,000.00
2017-09-30-$298,000.00
2017-06-30-$6.2M
2017-03-31-$3.42M-$2.75M$78,000.00-$82,000.00-$108,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$153.49M$307,000.00-$162.44M$289,000.00$61.56M$39.92M
2024-12-31-$126.87M$329,000.00-$96.77M$295,000.00-$20.61M$194.62M
2023-12-31-$102.24M$802,000.00-$76.38M$194,000.00-$953,000.00$116.93M
2022-12-31-$109.78M$924,000.00-$87.56M$254,000.00$1.06M$97.13M
2021-12-31-$110.82M$831,000.00-$84.89M$752,000.00$4.07M$72.32M
2020-12-31-$128.48M$416,000.00-$105.89M$1.22M$93.24M$16.53M
2019-12-31-$105.15M$300,000.00-$71.02M$325,000.00-$145.59M$165.25M
2018-12-31-$75.66M$400,000.00-$37.33M$560,000.00$35.29M$66.42M
2017-12-31-$20M$200,000.00-$9.57M$271,000.00-$36.28M$61.59M
2016-12-31-$1.94M$200,000.00$4.19M$695,000.00-$719,000.00-$9,000.00
2015-12-31-$12.69M-$7.18M$301,000.00-$301,000.00$21.58M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.